Literature DB >> 23377969

The p53/microRNA network in cancer: experimental and bioinformatics approaches.

Sabine Hünten1, Helge Siemens, Markus Kaller, Heiko Hermeking.   

Abstract

In the recent years, microRNAs (miRNAs) were identified as important components of the signaling cascades that mediate and regulate tumor suppression exerted by p53. This review illustrates some of the main principles that underlie the mechanisms by which miRNAs participate in p53's function and how they were identified. Furthermore, the current status of the research on the connection between p53 and miRNAs, as well as alterations in the p53/miRNA pathways found in cancer will be summarized and discussed. In addition, experimental and bioinformatics approaches, which can be applied to study the connection between p53 and miRNAs are described. Although, some of the central miRNA-encoding genes that mediate the effects of p53, such as the miR-34 and miR-200 families, have been identified, many additional analyses remain to be performed to fully elucidate the connections between p53 and miRNAs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377969     DOI: 10.1007/978-94-007-5590-1_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  34 in total

1.  Regulation of miR-34 Family in Neuronal Development.

Authors:  Abhishek Jauhari; Tanisha Singh; Parul Singh; Devendra Parmar; Sanjay Yadav
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

Review 2.  Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.

Authors:  Jasjit K Banwait; Dhundy R Bastola
Journal:  Adv Drug Deliv Rev       Date:  2014-11-06       Impact factor: 15.470

Review 3.  microRNAs and Alu elements in the p53-Mdm2-Mdm4 regulatory network.

Authors:  Yonit Hoffman; Yitzhak Pilpel; Moshe Oren
Journal:  J Mol Cell Biol       Date:  2014-06       Impact factor: 6.216

Review 4.  Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.

Authors:  Satyanarayana Rachagani; Muzafar A Macha; Nicholas Heimann; Parthasarathy Seshacharyulu; Dhanya Haridas; Seema Chugh; Surinder K Batra
Journal:  Adv Drug Deliv Rev       Date:  2014-10-23       Impact factor: 15.470

Review 5.  Mesenchymal stroma: primary determinant and therapeutic target for epithelial cancer.

Authors:  Sandro Goruppi; G Paolo Dotto
Journal:  Trends Cell Biol       Date:  2013-09-25       Impact factor: 20.808

6.  p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) Analyses.

Authors:  Sabine Hünten; Markus Kaller; Friedel Drepper; Silke Oeljeklaus; Thomas Bonfert; Florian Erhard; Anne Dueck; Norbert Eichner; Caroline C Friedel; Gunter Meister; Ralf Zimmer; Bettina Warscheid; Heiko Hermeking
Journal:  Mol Cell Proteomics       Date:  2015-07-16       Impact factor: 5.911

7.  MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.

Authors:  D Jeong; J Kim; J Nam; H Sun; Y-H Lee; T-J Lee; R C T Aguiar; S-W Kim
Journal:  Leukemia       Date:  2015-04-27       Impact factor: 11.528

Review 8.  HPV-p53-miR-34a axis in HPV-associated cancers.

Authors:  Jiezhong Chen; Kong-Nan Zhao
Journal:  Ann Transl Med       Date:  2015-12

Review 9.  Cellular reprogramming in skin cancer.

Authors:  Ihn Young Song; Allan Balmain
Journal:  Semin Cancer Biol       Date:  2014-04-08       Impact factor: 15.707

Review 10.  Caught in the cross fire: p53 in inflammation.

Authors:  Tomer Cooks; Curtis C Harris; Moshe Oren
Journal:  Carcinogenesis       Date:  2014-06-18       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.